Ledger.Open graph →
SEC Form D · Amendment · filed August 24, 2021

OcuTerra Therapeutics, Inc

Offering
$50.0M
Sold
$31.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Robert H. Dempsey · Boston, MADirectorBrent H. Saunders · Boston, MADirectorWilliam H. Koster · Boston, MADirectorKerrie H. Brady · Boston, MAExec · DirectorRobert H. Ruffolo · Boston, MADirectorDavid S. Edwards · Boston, MAExec · PromoterRobin H. Steele · Boston, MADirectorTomas Rosenthal · Brooklyn, NYDirectorErik Vaughan · Hudson, OHDirectorMorgan Hewett · WEST HOLLYWOOD, CAExec · DirectorKyle Pierce · WEST HOLLYWOOD, CAExec · PromoterBrandon Zimmerman · Washington, Washington, D.C.DirectorJ. J. Lobell · Miami, FLDirectorEllsworth JV LLC · Baltimore, MDDirectorLance Ollinger · Amarillo, TXExec · PromoterErik Spain · Amarillo, TXExec · DirectorPete Vlastelica · San Francisco, CADirectorScott G. Pasquini · CHICAGO, ILDirectorZaid F. Alsikafi · CHICAGO, ILDirectorY. S. Cakir · Columbus, OHDirectorZahara W. Kanji-Aquino · VANCOUVER, British Columbia, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗